Welcome!

News Feed Item

First Licensing Deals for Stem Cell Company Accellta

First licensing deals for stem cell company Accellta- this month the company announced that it granted worldwide, non-exclusive rights to Miltenyi Biotec to use one of Accellta’s patents in manufacturing and commercialization of Miltenyi Biotec’s proprietary medium for stem cell cultivation. Miltenyi Biotec is active worldwide and is one of the innovative leaders in products, services and clinical applications for biomedical research and cell therapy.

Several months ago, Accellta granted a similar license to Japanese nutrition and health giant, Ajinomoto. The non-exclusive license includes manufacturing and marketing rights of the medium in Japan, for both research and commercial applications. Ajinomoto has operations in 26 countries and encompasses a wide range of food and nutrition products, amino acids, chemicals and pharmaceuticals, with annual revenues exceeding USD 11 billion.

Accellta offers a range of revolutionary solutions for better affordability and quality of stem cell culturing and for developing disease models. The company was established in November 2012 by the Technion and AMIT (the Alfred Mann Institute at the Technion); its unique solutions are the result of over 15 years of pioneering research and development at the Stem Cell Center in the Rappaport Faculty of Medicine at the Technion- Israel Institute of Technology.

"The licensing deals leverage Accellta's intellectual property and allow us to offer our unique solutions to stem cell scientists and researchers worldwide, the number of which is estimated at over 100,000," says Accellta Chairman, Dr. Zeev Gilkis. "We believe these deals pave the way for more collaborations with the biomedical industry."

Since it was established, Accellta invested in creating strategic business collaborations and building physical infrastructure for clinical grade cell manufacturing. Recently it completed the construction of a state-of-the-art manufacturing facility, which will be used for industrial scale manufacturing of clinical-grade stem cells. The complex, which will serve the emerging regenerative therapy industry, is located in Haifa, Israel and includes 550 sqm of clean rooms, QC laboratories, R&D laboratories and offices.

According to Dr. Michal Amit, one of the world pioneers in stem cell research and Accellta's R&D manager, "The new manufacturing facility, together with Accellta's innovative solutions, allow both stem cell companies and research labs to culture higher quality cells in a faster, more uniform, and much more cost-effective manner."

Among Accellta's proprietary solutions: MAXELLS- a proprietary technology for cost-effective industrialization of stem cell manufacturing. Maxells uses suspension culturing and delivers unparalleled scalability and quality; SINGLES- a breakthrough technology for simple and effective culturing of stem cells as single-cells in suspension, which serves as a platform for genetic manipulation and provides enhanced uniformity and purity. In addition Accellta markets several stem cell lines and unique feeder cells.

Nowadays Accellta is focused on creating strategic partnerships with Biopharma companies and Stem Cell companies for developing economic manufacturing processes for cell products and for developing model systems for new drug screening and testing. In the future the company will also enter the market of regenerative medicine and develop therapies for currently incurable diseases.

About Accellta

Accellta develops, manufactures and markets a range of revolutionary solutions for better affordability and quality of stem cell culturing. Accellta's technologies are the result of over 15 years of pioneering research and development at the Stem Cell Center in the Technion’s Rappaport Faculty of Medicine. Accellta is a subsidiary of the Alfred Mann Institute at the Technion (AMIT) and operates a state-of-the-art manufacturing facility, laboratories and offices in Haifa, Israel. www.accellta.com

About AMIT

AMIT- Alfred Mann Institute at the Technion is the Technion hub for biomedical innovation, active since 2006, it supports the development and commercialization of exceptional bio-medical technologies conceived by Technion researchers. The institute is chaired and funded by American Billionaire and Philanthropist Dr. Alfred E. Mann. AMIT owns three startup companies- Accellta, Sealantis and Sanoculis. www.amitechnion.com

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that MIRAI Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MIRAI Inc. are IT consultants from the public sector whose mission is to solve social issues by technology and innovation and to create a meaningful future for people.
Data scientists must access high-performance computing resources across a wide-area network. To achieve cloud-based HPC visualization, researchers must transfer datasets and visualization results efficiently. HPC clusters now compute GPU-accelerated visualization in the cloud cluster. To efficiently display results remotely, a high-performance, low-latency protocol transfers the display from the cluster to a remote desktop. Further, tools to easily mount remote datasets and efficiently transfer...
SYS-CON Events announced today that Dasher Technologies will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Dasher Technologies, Inc. ® is a premier IT solution provider that delivers expert technical resources along with trusted account executives to architect and deliver complete IT solutions and services to help our clients execute their goals, plans and objectives. Since 1999, we'v...
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, will provide a fun and simple way to introduce Machine Leaning to anyone and everyone. Together we will solve a machine learning problem and find an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intellige...
SYS-CON Events announced today that TidalScale, a leading provider of systems and services, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale has been involved in shaping the computing landscape. They've designed, developed and deployed some of the most important and successful systems and services in the history of the computing industry - internet, Ethernet, operating s...
SYS-CON Events announced today that TidalScale will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale is the leading provider of Software-Defined Servers that bring flexibility to modern data centers by right-sizing servers on the fly to fit any data set or workload. TidalScale’s award-winning inverse hypervisor technology combines multiple commodity servers (including their ass...
Recently, REAN Cloud built a digital concierge for a North Carolina hospital that had observed that most patient call button questions were repetitive. In addition, the paper-based process used to measure patient health metrics was laborious, not in real-time and sometimes error-prone. In their session at 21st Cloud Expo, Sean Finnerty, Executive Director, Practice Lead, Health Care & Life Science at REAN Cloud, and Dr. S.P.T. Krishnan, Principal Architect at REAN Cloud, will discuss how they b...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
Amazon is pursuing new markets and disrupting industries at an incredible pace. Almost every industry seems to be in its crosshairs. Companies and industries that once thought they were safe are now worried about being “Amazoned.”. The new watch word should be “Be afraid. Be very afraid.” In his session 21st Cloud Expo, Chris Kocher, a co-founder of Grey Heron, will address questions such as: What new areas is Amazon disrupting? How are they doing this? Where are they likely to go? What are th...
SYS-CON Events announced today that IBM has been named “Diamond Sponsor” of SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California.
We all know that end users experience the Internet primarily with mobile devices. From an app development perspective, we know that successfully responding to the needs of mobile customers depends on rapid DevOps – failing fast, in short, until the right solution evolves in your customers' relationship to your business. Whether you’re decomposing an SOA monolith, or developing a new application cloud natively, it’s not a question of using microservices – not doing so will be a path to eventual b...
Infoblox delivers Actionable Network Intelligence to enterprise, government, and service provider customers around the world. They are the industry leader in DNS, DHCP, and IP address management, the category known as DDI. We empower thousands of organizations to control and secure their networks from the core-enabling them to increase efficiency and visibility, improve customer service, and meet compliance requirements.
In his session at 21st Cloud Expo, Michael Burley, a Senior Business Development Executive in IT Services at NetApp, will describe how NetApp designed a three-year program of work to migrate 25PB of a major telco's enterprise data to a new STaaS platform, and then secured a long-term contract to manage and operate the platform. This significant program blended the best of NetApp’s solutions and services capabilities to enable this telco’s successful adoption of private cloud storage and launchi...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, will go over the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, applicatio...